City

Bron (1)

Maastricht (1)

Nantes (1)

Paris (1)

Philadelphia (1)

Condition

Gastrointestinal (3)

Breast Cancer (1)

Gut Damage (1)

Hypoperfusion (1)

Lung Cancer (1)

Lymphomatous Malignancies (1)

Tolerance (1)

Overall Status

Completed (2)

Unknown status (1)

Sign in for free

Phase

n/a (2)

Sponsor

Abramson Cancer Center of the University of Pennsylvania (1)

Cargill (1)

Maastricht University Medical Center (1)

Collaborator

Biofortis Merieux NutriSciences (1)

Top Institute Food and Nutrition (1)

Intervention

alanine (1)

citrulline (1)

erythritol drink (1)

placebo drink (1)

Study Documents

Intervention Type

dietary supplement (1)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

gastrointestinal

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

DIBH Proton Planning

Completed

Lung Cancer
+3 more

Philadelphia, Pennsylvania

Abramson Cancer Center of the University of Pennsylvania

Mar 9, 2020

Gastrointestinal, Tolerance Trial in Bron, Nantes, Paris (Erythritol drink, Placebo drink)

Completed

Gastrointestinal
Tolerance

Erythritol drink
Placebo drink

Bron, France
+2 more

Jul 18, 2017

Gastrointestinal, Hypoperfusion, Gut Damage Trial in Maastricht (Citrulline, alanine)

Unknown status

Gastrointestinal
+2 more

Citrulline
alanine

Maastricht, Limburg, Netherlands

Maastricht University Medical Center

Nov 7, 2011